
KERUIHK-0603

Lyophilized PowderProduct image
Immune & Thymic
MOTS-c
ResearchKERUIHK-0603
Mitochondria-derived peptide that regulates metabolic homeostasis, insulin sensitivity, and immune aging.
Product Specifications
- CAS Number
- 1627580-64-6
- Catalog Purity
- ≥99.03%
- Form
- Lyophilized Powder
- Catalog Grade
- Research
Product Details
MOTS-c specifications
Use the product name, catalog reference and available specifications below when discussing your requirements with our team.
- Product
- MOTS-c
- Catalog reference
- KERUIHK-0603
- CAS number
- 1627580-64-6
- Category
- Immune & Thymic
- Physical form
- Lyophilized Powder
Latest reported batch: MOTS-c
Batch PB-2026-MOT-3589 · Oct 26, 2026
- Sample specification
- 10 mg/vial
- Reported appearance
- White lyophilized powder
- Reported molecular weight / identity
- 2174.60 Da
- Analytical method
- RP-HPLC (214 nm) / ESI-HRMS
- Storage stated in this report
- −20°C, protect from light
Reported analytical results
- Appearance
- Conforms — White lyophilized powder; no visible particulates or cakingReport specification: White to off-white powderMethod: Visual inspection
- Solubility
- <30 s; clear and colorless; no suspended or undissolved particlesReport specification: Soluble in water (≥5 mg/mL)Method: 2.0 mL sterile water; gentle swirling
- HPLC Purity
- 99.60%Report specification: ≥99.0%Method: SOP-HPLC-MOT-001-v2
- Molecular Weight (MS)
- 2174.60 Da; −9.20 ppmReport specification: 2174.62 Da; within method toleranceMethod: SOP-MS-MOT-002 / ESI-HRMS
Show 5 more test results
- Amino Acid Analysis
- ConformsReport specification: Conforms to sequence MRWQEMGYIFYPRKLRMethod: AAA / USP <1052>
- Water Content (KF)
- 2.15%Report specification: ≤8.0%Method: Karl Fischer / USP <921>
- Residual Solvents
- Acetonitrile <80 ppm; Dichloromethane <30 ppm; DMF <50 ppmReport specification: ICH Q3C Class 2Method: GC-HS
- Sterility
- No microbial growth observedReport specification: No evidence of microbial growthMethod: 14-day sterility test
- Endotoxin (LAL)
- < 0.20 EU/mgReport specification: < 5.0 EU/mgMethod: USP <85> gel-clot; reporting limit 0.10 EU/mg
Batch Documentation
Certificates of Analysis
Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.
PB-2026-MOT-3589Report product: MOTS-c · 10 mg/vialOct 26, 2026 · Reported purity: 99.60%View this batch COA
Show 2 earlier reports
Product Inquiry
Request a MOTS-c quotation
We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

